Specifically, IL-6 can promote pro-inflammatory signaling that is linked to cancer progression; it is highly expressed in many cancer types, including colorectal, breast, lung, and pancreatic cancer; correlates with poor survival, and aids in EMT-mediated cancer cell invasion [38,39]. Here, IL6 is linked to cancer.